- Home
- IMMX vs TORO Comparison
IMMX vs TORO Comparison
Compare IMMX & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- TORO
- Stock Information
- Founded
- IMMX 2014
- TORO 2022
- Country
- IMMX United States
- TORO Cyprus
- Employees
- IMMX N/A
- TORO N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- TORO Marine Transportation
- Sector
- IMMX Health Care
- TORO Consumer Discretionary
- Exchange
- IMMX Nasdaq
- TORO Nasdaq
- Market Cap
- IMMX 50.1M
- TORO 45.1M
- IPO Year
- IMMX 2021
- TORO N/A
- Fundamental
- Price
- IMMX $2.09
- TORO $1.88
- Analyst Decision
- IMMX Strong Buy
- TORO
- Analyst Count
- IMMX 1
- TORO 0
- Target Price
- IMMX $7.00
- TORO N/A
- AVG Volume (30 Days)
- IMMX 59.6K
- TORO 60.8K
- Earning Date
- IMMX 05-20-2025
- TORO 05-20-2025
- Dividend Yield
- IMMX N/A
- TORO N/A
- EPS Growth
- IMMX N/A
- TORO N/A
- EPS
- IMMX N/A
- TORO 1.09
- Revenue
- IMMX N/A
- TORO $22,394,283.00
- Revenue This Year
- IMMX N/A
- TORO N/A
- Revenue Next Year
- IMMX N/A
- TORO N/A
- P/E Ratio
- IMMX N/A
- TORO $1.74
- Revenue Growth
- IMMX N/A
- TORO 0.40
- 52 Week Low
- IMMX $1.26
- TORO $1.70
- 52 Week High
- IMMX $2.71
- TORO $4.85
- Technical
- Relative Strength Index (RSI)
- IMMX 61.41
- TORO 40.31
- Support Level
- IMMX $1.92
- TORO $1.79
- Resistance Level
- IMMX $2.25
- TORO $2.03
- Average True Range (ATR)
- IMMX 0.17
- TORO 0.11
- MACD
- IMMX 0.03
- TORO 0.02
- Stochastic Oscillator
- IMMX 67.61
- TORO 37.50
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.